Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing
Background Activating mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) are predictive biomarkers for response to EGFR-tyrosine kinase inhibitor (TKI) therapy in lung adenocarcinoma (LUAD). Here, we characterized the clinicopathologic features associated with EGFR mu...
Saved in:
Main Authors: | Jeonghyo Lee (Author), Yeon Bi Han (Author), Hyun Jung Kwon (Author), Song Kook Lee (Author), Hyojin Kim (Author), Jin-Haeng Chung (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteosarcomatous Differentiation in Rebiopsy Specimens of Pulmonary Adenocarcinoma with EGFR-TKI Resistance
by: Hyein Ahn, et al.
Published: (2018) -
The incorporation of next-generation sequencing into pediatric care
by: Ni-Chung Lee
Published: (2023) -
Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes
by: Zihan Zhou, et al.
Published: (2022) -
Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics
by: Bing Cao, et al.
Published: (2024) -
Targeted next-generation sequencing for the detection of cancer-associated somatic mutations in adenomyosis
by: Angel Chao, et al.
Published: (2023)